Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
4.99 USD | -9.27% | +9.78% | +52.11% |
Financials (USD)
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 145M |
---|---|---|---|---|---|
Net income 2024 * | -29M | Net income 2025 * | -30M | EV / Sales 2024 * | - |
Net cash position 2024 * | 12.42M | Net Debt 2025 * | 19.19M | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-5.48
x | P/E ratio 2025 * |
-6.96
x | Employees | 140 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 26.67% |
Latest transcript on Rani Therapeutics Holdings, Inc.
1 day | +7.42% | ||
1 week | +23.87% | ||
1 month | -13.66% | ||
3 months | +49.05% | ||
6 months | +125.41% | ||
Current year | +65.66% |
Managers | Title | Age | Since |
---|---|---|---|
Talat Imran
CEO | Chief Executive Officer | 43 | 21-05-31 |
Mir Imran
FOU | Founder | 67 | 21-04-05 |
Svai Sanford
DFI | Director of Finance/CFO | 54 | 21-04-05 |
Members of the board | Title | Age | Since |
---|---|---|---|
Laureen DeBuono
BRD | Director/Board Member | 66 | 21-04-05 |
Jean-Luc Butel
BRD | Director/Board Member | 67 | 21-04-05 |
Dennis Ausiello
BRD | Director/Board Member | 78 | 21-04-05 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.02% | 0 M€ | 0.00% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-06-03 | 4.99 | -9.27% | 135 665 |
24-05-31 | 5.5 | +7.42% | 136,087 |
24-05-30 | 5.12 | +2.40% | 68,580 |
24-05-29 | 5 | +8.70% | 65,683 |
24-05-28 | 4.6 | +3.60% | 86,859 |
Delayed Quote Nasdaq, May 31, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+65.66% | 145M | |
+11.60% | 106B | |
-4.68% | 24.28B | |
-0.29% | 21.96B | |
-8.61% | 18.16B | |
-42.12% | 16.37B | |
-17.47% | 15.56B | |
+2.77% | 13.63B | |
+34.58% | 12.27B | |
+77.64% | 8.87B |
- Stock Market
- Equities
- RANI Stock